Sinovac Biotech Ltd (SVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Sales | 71,774 | 49,210 | 56,840 | 33,400 | 84,190 |
| Cost of Goods | 20,505 | 19,100 | 21,120 | 16,710 | 20,060 |
| Gross Profit | 51,269 | 30,110 | 35,710 | 16,680 | 64,130 |
| Operating Expenses | 41,828 | 49,540 | 32,750 | 31,420 | 23,390 |
| Operating Income | 9,946 | -19,330 | 3,090 | -14,020 | 40,800 |
| Interest Expense | 3,031 | 770 | 380 | 1,170 | 530 |
| Other Income | 2,496 | 470 | 1,950 | 1,890 | 1,280 |
| Pre-tax Income | 9,411 | -19,630 | 4,660 | -13,300 | 41,550 |
| Income Tax | -2,225 | -880 | 5,060 | -700 | 11,140 |
| Net Income Continuous | 11,636 | -14,704 | -845 | -8,507 | 19,958 |
| Net Income Discontinuous | -1,266 | 0 | 0 | 0 | 0 |
| Minority Interests | 2,928 | N/A | N/A | N/A | N/A |
| Net Income | $7,442 | $-18,740 | $-400 | $-12,600 | $30,410 |
| EPS Basic Total Ops | 0.13 | -0.29 | -0.02 | -0.16 | 0.47 |
| EPS Basic Continuous Ops | 0.21 | -0.27 | -0.02 | -0.16 | 0.47 |
| EPS Basic Discontinuous Ops | -0.02 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | 0.13 | -0.29 | -0.02 | -0.16 | 0.46 |
| EPS Diluted Continuous Ops | 0.21 | -0.27 | -0.02 | -0.16 | 0.46 |
| EPS Diluted Discontinuous Ops | -0.02 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $16,043 | $-14,850 | $7,910 | $-9,790 | $43,030 |